NNNN vs SRT3: Side-by-Side Comparison
Compare Anbio Biotechnology - Class A (NNNN) and Sartorius Aktiengesellschaft (SRT3) side by side: market cap USD 557.42M vs EUR 15.83B. Financials, growth and model signals on Bullrun.
| Metric | NNNN | SRT3 |
|---|---|---|
| Company | Anbio Biotechnology - Class A | Sartorius Aktiengesellschaft |
| Country / Exchange | Germany · NASDAQ | Germany · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
| Market cap | USD 557.42M | EUR 15.83B |
| P/E ratio | — | 97.9 |
| Dividend yield | — | 0.32% |
| Valuation model | — | 42.9% overvalued |
| Revenue (latest FY) | USD 8.65M | — |
| Revenue growth YoY | +5.6% | — |
| Net income | USD 6.40M | — |
| Gross margin | 87.2% | — |
| Diluted EPS | 0.15 | — |